Records 1 - 3 (of 3 Records)
|Query Trace: Hypothyroidism and ABCB1[original query]|
| Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma.
Oncotarget 2018 Mar 9 (24): 17160-17170.
Yamamoto Yoshiaki, Tsunedomi Ryouichi, Fujita Yusuke, Otori Toru, Ohba Mitsuyoshi, Kawai Yoshihisa, Hirata Hiroshi, Matsumoto Hiroaki, Haginaka Jun, Suzuki Shigeo, Dahiya Rajvir, Hamamoto Yoshihiko, Matsuyama Kenji, Hazama Shoichi, Nagano Hiroaki, Matsuyama Hideya
| Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma.
Medical oncology (Northwood, London, England) 2018 Mar 35 (4): 51.
Igarashi Ryoma, Inoue Takamitsu, Fujiyama Nobuhiro, Tsuchiya Norihiko, Numakura Kazuyuki, Kagaya Hideaki, Saito Mitsuru, Narita Shintaro, Satoh Shigeru, Niioka Takenori, Miura Masatomo, Habuchi Tomono
| Impact of Genetic Variants on Postoperative Pain and Fentanyl Dose Requirement in Patients Undergoing Major Breast Surgery: A Candidate Gene Association Study.
Anesthesia and analgesia 2022 12 .
Kumar Shathish, Kesavan Ramasamy, Sistla Sarath Chandra, Penumadu Prasanth, Natarajan Harivenkatesh, Nair Sreekumaran, Chakradhara Rao Uppugunduri S, Venkatesan Vasuki, Kundra Pank